We asked our speakers why translational research is important. Read what they have to say.

The 2025 Annual Meeting of the Indiana CTSI is on November 21, 2025. View the meeting details and register today.

We asked our speakers how translational research makes a difference in the lives of people with diabetes. Here is what some of them had to say.

“Translational science facilitates persons living with diabetes rapidly accessing advances made possible through science to improve health outcomes. These advances include earlier diabetes detection, new drug recovery and innovative drug delivery, and advanced glucose monitoring strategies.” – Linda A. DiMeglio, MD, MPH, Edwin Letzter Professor of Pediatrics, Division Chief, Pediatric Endocrinology and Diabetology, IU School of Medicine

“It allows them to live a more full and meaningful life with a burdensome chronic disease.” – Tamara S. Hannon, MD, Professor of Pediatrics and Medical and Molecular Genetics, Director, Clinical Diabetes Program, IU School of Medicine

“Advancements in translational research have the potential to bring cost-effective and accessible technologies to individuals with diabetes, helping improve care regardless of socioeconomic status or insurance coverage.” – Mangilal Agarwal, PhD, Director, Integrated Nanosystems Development Institute; Professor & Interim Chair of Biomedical Engineering & Informatics, Luddy School of Informatics, Computing, and Engineering, Indiana University

“Translational science has the potential to transform blood glucose monitoring and diabetes management by accelerating the application of research into practical tools, ultimately improving health outcomes and quality of life for individuals living with, or at risk for, diabetes.” –Mark Woollam, PhD, Senior Research Scientist, Integrated Nanosystems Development Institute, IU Indianapolis, School of Science

“Translational science brings discovery from lab to clinics. From FDA approved therapies to delay type 1 diabetes to effective management of diabetes by CGM and automated insulin deliveries, all were possible due to strong science.” – Viral Shah, MD, Professor of Medicine, Director, Diabetes Clinical Research, IU Center for Diabetes and Metabolic Diseases, IU School of Medicine

We will share more of these insightful, inspiring answers from our speakers soon. Watch for these and other updates leading up to the meeting on November 21. Register by November 7 to secure your spot!